HBV AND 1018 ISS VACCINE FORMULATION IN NEWBORN BABOONS

新生狒狒的 HBV 和 1018 ISS 疫苗配方

• 批准号: 7562437
• 负责人: KATHLEEN M BRASKY
• 金额: $ 0.26万
• 依托单位: TEXAS BIOMEDICAL RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-05-01 至 2008-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7562437
• 关键词: Adult; Antibodies; Antibody Formation; Computer Retrieval of Information on Scientific Projects Database; DNA Sequence; Development; Dose; Drug Formulations; Funding; Grant; Hepatitis B Surface Antigens; Hepatitis B Vaccines; Hepatitis B Virus; Human; Infant; Institution; Modeling; Newborn Infant; Papio; Recombinants; Research; Research Personnel; Resources; Source; Testing; Time; United States National Institutes of Health; Vaccines; Yeasts; immunogenicity; research study; response; vaccination schedule

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This is a two-part study. The objective of this experiment is to test for the first time in newborn baboons the immunogenicity of a hepatitis B virus (HBV) vaccine formulation, consisting of immunostimulatory DNA sequences (1018 ISS) mixed with yeast-recombinant hepatitis B surface antigen (HBsAg). This experiment will help determine if this vaccine can elicit antibodies in newborn baboons, and help identify the optimal dose for 1018 ISS, and the optimal vaccination schedule. This study will evaluate the ability of this vaccine to induce an antibody response in baboons to HBsAg equivalent to a commercial vaccine formulation that is used to immunize human infants. Historically, adult baboons have shown to be a good model for HBV vaccines, such as those containing HBsAg plus 1018 ISS. These studies will help decide if the HBV and ISS vaccine formulation can elicit responses in newborn baboons equivalent to the commercial HBV vaccine, which will assist in the development of a new HBV vaccine for human infants.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这是一项分两部分的研究。 本实验的目的是首次在新生狒狒中检测B型肝炎病毒（HBV）疫苗制剂的免疫原性，该疫苗制剂由免疫刺激性DNA序列（1018 ISS）与酵母重组B型肝炎表面抗原（HBsAg）混合组成。 这项实验将有助于确定这种疫苗是否可以在新生狒狒中引发抗体，并有助于确定1018 ISS的最佳剂量和最佳疫苗接种时间表。 本研究将评价该疫苗在狒狒中诱导HBsAg抗体应答的能力，该抗体应答相当于用于免疫人类婴儿的商业疫苗制剂。 从历史上看，成年狒狒已被证明是HBV疫苗的良好模型，例如含有HBsAg加1018 ISS的疫苗。 这些研究将有助于确定HBV和ISS疫苗制剂是否可以在新生狒狒中引起相当于商业HBV疫苗的反应，这将有助于开发用于人类婴儿的新HBV疫苗。